The Clinical Times
The Front Page of Medicine

Latest medical news · page 48

The latest headlines across every section, pulled from official and open-access sources.

WHO · May 28, 2026

Message by the WHO Director-General to the people of the Democratic Republic of the Congo

To the people of DRC, especially to the people of Ituri  Jambo kwenu wakahaji wa Ituri  Mbote na bino, bato ya Ituri  My name is Tedros, and I am the Director-General of the World Health Organization (WHO). But today, I am not writing to you as an official. I am writing to you as someone who knows your region, who has walked your streets, and who cares deeply about what happens to you and your families.  I am writing because I want to be with you in these moments. And I want you to know that you are not alone.  Ebola is not new to me personally. From 2018 to 2020, I…

JAMA Clinical Reviews · May 27, 2026

Cesarean Delivery on Request

Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation. Author Marianna Alperin, MD, MS, from UC San Diego School of Medicine, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD. Related Content: Cesarean Delivery on Maternal Request Cesarean Delivery—Reply Cesarean Delivery

NEJM This Week · May 27, 2026

NEJM This Week — May 28, 2026

This week, we present new research guiding treatment of pulmonary embolism, early progress in cardiac regeneration with engineered heart tissue, and treatments for gastroesophageal cancer and Chiari malformation. We review leishmaniasis and follow a revealing neurologic case. Perspectives discuss nutrition policy, tickborne illness, structural competence in medicine, and the arrival of closure.

PLOS Medicine · May 27, 2026

Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial

by Wei-Xiang Qi, Shuyan Li, Mengdi Wang, Huan Li, Feifei Xu, Lei Yao, Biao Yu, Linlin Chen, Gang Cai, Cheng Xu, Xianwen Sun, Zhiyao Bao, Jiayi Chen, Yi Xiang, Shengguang Zhao Background The appropriateness of concurrent chemoradiotherapy (cCRT) for older or clinically vulnerable stage III unresectable non-small-cell lung cancer (NSCLC) patients remains contentious. Furthermore, the survival implications of de-escalating thoracic radiotherapy (RT) intensity in this population have not been conclusively elucidated. Methods and findings We conducted a phase II randomized, open-label, two-cohort…

← NewerOlder →

Back to the live front page